Parallel Advisors’s Theravance Biopharma TBPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-240
| Closed | -$2.26K | – | 3652 |
|
|
2024
Q4 | $2.26K | Buy |
+240
| New | +$2.26K | ﹤0.01% | 2908 |
|
|
2024
Q3 | – | Sell |
-186
| Closed | -$1.58K | – | 3464 |
|
|
2024
Q2 | $1.58K | Buy |
186
+78
| +72% | +$661 | ﹤0.01% | 2845 |
|
|
2024
Q1 | $969 | Sell |
108
-1,501
| -93% | -$13.5K | ﹤0.01% | 2938 |
|
|
2023
Q4 | $18.1K | Buy |
1,609
+1,370
| +573% | +$15.4K | ﹤0.01% | 2002 |
|
|
2023
Q3 | $2.06K | Buy |
+239
| New | +$2.06K | ﹤0.01% | 2805 |
|
|
2022
Q4 | – | Sell |
-215
| Closed | -$2K | – | 3520 |
|
|
2022
Q3 | $2K | Buy |
+215
| New | +$2K | ﹤0.01% | 2739 |
|
|
2022
Q1 | – | Sell |
-1,899
| Closed | -$21K | – | 3272 |
|
|
2021
Q4 | $21K | Buy |
1,899
+994
| +110% | +$11K | ﹤0.01% | 1752 |
|
|
2021
Q3 | $7K | Buy |
905
+747
| +473% | +$5.78K | ﹤0.01% | 2230 |
|
|
2021
Q2 | $2K | Hold |
158
| – | – | ﹤0.01% | 2591 |
|
|
2021
Q1 | $3K | Hold |
158
| – | – | ﹤0.01% | 2387 |
|
|
2020
Q4 | $3K | Hold |
158
| – | – | ﹤0.01% | 2204 |
|
|
2020
Q3 | $2K | Hold |
158
| – | – | ﹤0.01% | 2329 |
|
|
2020
Q2 | $3K | Hold |
158
| – | – | ﹤0.01% | 2122 |
|
|
2020
Q1 | $3K | Hold |
158
| – | – | ﹤0.01% | 2052 |
|
|
2019
Q4 | $4K | Hold |
158
| – | – | ﹤0.01% | 2051 |
|
|
2019
Q3 | $3K | Hold |
158
| – | – | ﹤0.01% | 2084 |
|
|
2019
Q2 | $3K | Hold |
158
| – | – | ﹤0.01% | 2004 |
|
|
2019
Q1 | $4K | Hold |
158
| – | – | ﹤0.01% | 1889 |
|
|
2018
Q4 | $4K | Hold |
158
| – | – | ﹤0.01% | 1677 |
|
|
2018
Q3 | $5K | Hold |
158
| – | – | ﹤0.01% | 1745 |
|
|
2018
Q2 | $3K | Sell |
158
-35
| -18% | -$665 | ﹤0.01% | 1769 |
|
|
2018
Q1 | $5K | Hold |
193
| – | – | ﹤0.01% | 1582 |
|
|
2017
Q4 | $5K | Hold |
193
| – | – | ﹤0.01% | 1596 |
|
|
2017
Q3 | $5K | Hold |
193
| – | – | ﹤0.01% | 1609 |
|
|
2017
Q2 | $6K | Hold |
193
| – | – | ﹤0.01% | 1542 |
|
|
2017
Q1 | $8K | Hold |
193
| – | – | ﹤0.01% | 1323 |
|
|
2016
Q4 | $6K | Buy |
+193
| New | +$6K | ﹤0.01% | 1317 |
|